uridine has been researched along with Recrudescence in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abudawood, M; Al-Eidi, H; Alatar, G; Alhaidan, Y; Almuzzaini, B; AlSaud, NA; AlSubait, A; AlTuwaijri, A; AlWadaani, D; Matou-Nasri, S; Najdi, M; Trivilegio, T | 1 |
Häyry, P; Savikko, J; Von Willebrand, E | 1 |
Barinskiĭ, IF; Ershov, FI; Galegov, GA; Zhdanov, VM | 1 |
Kappas, A; Sassa, S; Zalar, GL | 1 |
1 review(s) available for uridine and Recrudescence
Article | Year |
---|---|
[Herpetic pathology and current methods of treating herpetic lesions].
Topics: Bromouracil; Combined Modality Therapy; Female; Fluorenes; Herpes Genitalis; Herpes Simplex; Humans; Idoxuridine; Interferon Inducers; Keratitis, Dendritic; Levamisole; Male; Megacins; Poly A-U; Recurrence; Uridine; Vaccination; Vidarabine; Viral Vaccines | 1983 |
3 other study(ies) available for uridine and Recrudescence
Article | Year |
---|---|
Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling.
Topics: Apoptosis; Cell Line; Humans; Leukemia, Myeloid, Acute; MicroRNAs; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Recurrence; Stem Cells; Uridine | 2022 |
Leflunomide analogue FK778 is vasculoprotective independent of its immunosuppressive effect: potential applications for restenosis and chronic rejection.
Topics: Alkynes; Angiogenesis Inhibitors; Animals; Benzamides; Blood Vessels; Constriction, Pathologic; Dihydroorotate Dehydrogenase; Graft Rejection; Imatinib Mesylate; Immunosuppressive Agents; Isoxazoles; Male; Nitriles; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Wistar; Recurrence; Tunica Intima; Uridine; Vascular Diseases | 2003 |
Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
Topics: Acute Disease; Adolescent; Adult; Aged; Ammonia-Lyases; Cells, Cultured; Child; Child, Preschool; Enzyme Induction; Female; Humans; Hydroxymethylbilane Synthase; Lymphocytes; Male; Middle Aged; Mitogens; Porphyrias; Recurrence; Stimulation, Chemical; Thymidine; Uridine | 1978 |